 |
Hyaluronic Acid
Research News and Information
Definition of 'Hyaluronic Acid'A natural high-viscosity mucopolysaccharide with alternating beta (1-3) glucuronide and beta (1-4) glucosaminidic bonds. It is found in the UMBILICAL CORD, in VITREOUS BODY and in SYNOVIAL FLUID. A high urinary level is found in PROGERIA. Common names: Hyaluronic Acid; Acid, Hyaluronic; Amvisc; Bausch and Lomb Brand of Sodium Hyaluronate; Biolon; Akorn, Inc. Brand of Sodium Hyaluronate; Etamucine; Hyaluronan; Hyvisc; Anika Therapeutics Brand of Sodium Hyaluronidate; Luronit; Sodium Hyaluronate; Hyaluronate, Sodium; Hyaluronate Sodium; Amo Vitrax |
Saturday, November 21, 2009
Viability and differentiation of neural precursors on hyaluronic acid hydrogel scaffold.
30 Oct 2009 
The traditional notion that injured neurons are unable to regenerate in the adult mammalian brain and spinal cord has long been a concern. This view has led to methodology designed to overcome this problem, most recently by advancements in tissue ... Read more...
30 Oct 2009 Knee osteoarthritis (OA) is a cause of decline in function and the medial compartment is often affected. Intraarticular injection of hyaluronic acid (HA) is indicated as a symptom modifying treatment with at least 6 months passing between ... Read more...
29 Sep 2009 The ultrastructural study of rare cells within their niche in situ is very difficult. We have developed a method for locating individual transplanted cells and simultaneously identifying and analyzing the molecules and cellular phenotypes ... Read more...
Latest indexed articles for 'Hyaluronic Acid'
These are the very latest articles for this heading:
- Viability and differentiation of neural precursors on hyaluronic acid hydrogel scaffold. 30 Oct 2009
- Medial knee joint loading increases in those who respond to hyaluronan injection for medial knee osteoarthritis. 30 Oct 2009
- An innovative triple immunogold labeling method to investigate the hemopoietic stem cell niche in situ. 29 Sep 2009
- The filler revolution: a six-year retrospective. 29 Sep 2009
- Inhibition of dendritic cell maturation by group A Streptococcus. 29 Sep 2009
- Editorial comment.
29 Sep 2009 - Formation of cartilage repair tissue in articular cartilage defects pretreated with microfracture and covered with cell-free polymer-based implants. 29 Sep 2009
- Critical organ preservation in reirradiation brachytherapy by injectable spacer. 29 Sep 2009
- Targeted delivery of chemotherapeutic agents using improved radiosensitive liquid core microcapsules and assessment of their antitumor effect. 29 Sep 2009
- A reappraisal of the biological effects of hyaluronan on human dermal fibroblast. 13 Sep 2009
- Postoperative intra-abdominal collections using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier at the time of laparotomy for ovarian, fallopian tube, or primary peritoneal cancers. 6 Sep 2009
- Enhancing action by sulfated hyaluronan on connexin-26, -32, and -43 gene expressions during the culture of normal human astrocytes. 30 Aug 2009
- Hyaluronic acid complexed to biodegradable poly L-arginine for targeted delivery of siRNAs. 30 Aug 2009
- Blood hyaluronic acid as a marker for canine cirrhosis. 30 Aug 2009
- Early requirement of Hyaluronan for tail regeneration in Xenopus tadpoles. 30 Aug 2009
- A split-face comparison of a new hyaluronic acid facial filler containing pre-incorporated lidocaine versus a standard hyaluronic acid facial filler in the treatment of naso-labial folds. 30 Aug 2009
- Novel hyaluronate-atelocollagen/beta-TCP-hydroxyapatite biphasic scaffold for the repair of osteochondral defects in rabbits. 30 Aug 2009
- Architectural organization and functional features of early endothelial progenitor cells cultured in a hyaluronan-based polymer scaffold. 30 Aug 2009
- Decreased physical function and increased pain sensitivity in mice deficient for type IX collagen. 30 Aug 2009
- Evaluation of angiogenic activities of hyaluronan oligosaccharides of defined minimum size. 27 Aug 2009
See a longer list of these articles.
Technical information about 'Hyaluronic Acid'
Definition: A natural high-viscosity mucopolysaccharide with alternating beta (1-3) glucuronide and beta (1-4) glucosaminidic bonds. It is found in the UMBILICAL CORD, in VITREOUS BODY and in SYNOVIAL FLUID. A high urinary level is found in PROGERIA.
Chemical name: Hyaluronic acid
Registry Number: 9004-61-9
Descriptor UI: D006820
Alternative terms: Hyaluronic Acid; Acid, Hyaluronic; Amvisc; Bausch and Lomb Brand of Sodium Hyaluronate; Biolon; Akorn, Inc. Brand of Sodium Hyaluronate; Etamucine; Hyaluronan; Hyvisc; Anika Therapeutics Brand of Sodium Hyaluronidate; Luronit; Sodium Hyaluronate; Hyaluronate, Sodium; Hyaluronate Sodium; Amo Vitrax; Vitrax, Amo; Advanced Medical Optics, Inc. Brand of Sodium Hyaluronate; Healon; Advanced Medical Optics Brand of Sodium Hyaluronidate;
Allowable Qualifiers: administration & dosage; adverse effects; analogs & derivatives; analysis; antagonists & inhibitors; biosynthesis; blood; cerebrospinal fluid; chemical synthesis; classification; deficiency; diagnostic use; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; physiology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists; ultrastructure;
Pharmacological Action: Viscosupplements; Adjuvants, Immunologic;
Tree Number: D09.698.373.475;
History Note: 2002; for BIOLON use POLYMETHYL METHACRYLATE 1977-2001